ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02889328
Brief Title: Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs

First Submitted : August 31, 2016
First Submitted that Met QC Criteria : August 31, 2016
First Posted : September 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 5, 2018
Last Update Posted : February 6, 2018